Clinical Trials in Illinois

Showing 6361-6380 of 14,943 trials

Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD

NCT00667459

The purpose of this clinical trial is to evaluate the safety and effectiveness of the PRESTIGE® LP Cervical Disc as a method of treating patients with symptoms of cervical degenerative disc disease at a single level from C3-C4 to C6-C7.

Cervical Degenerative Disc Disease

Medtronic Spinal and Biologics280 participantsStarted Jan 2005

Atlanta, Georgia, United States • Columbus, Georgia, United States • Coeur d'Alene, Idaho, United States +13 more locations

COMPLETEDPhase 340 miles

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

NCT00134030

This randomized phase III trial is studying combination chemotherapy followed by surgery and two different combination chemotherapy regimens with or without PEG-interferon alfa-2b to compare how well they work in treating patients with osteosarcoma. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Biological therapies, such as PEG-interferon alfa-2b, may interfere with the growth of tumor cells. Giving combination chemotherapy before surgery may shrink the tumor so it can be removed. Giving combination chemotherapy together with PEG-interferon alfa-2b after surgery may kill any remaining tumor cells. It is not yet known whether giving combination therapy together with PEG-interferon alfa-2b is more effective than two different combination chemotherapy regimens alone after surgery in treating osteosarcoma.

Localized OsteosarcomaMetastatic Osteosarcoma

Children's Oncology Group1,334 participantsStarted Nov 2005

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +215 more locations

Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

Find Trials by Condition in Illinois

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis

Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

International Hernia Mesh Registry

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

A Study Evaluating the Safety and Effectiveness of the PulseRider® Aneurysm Neck Reconstruction Device Used in Conjunction With Endovascular Coil Embolization in the Treatment of Wide-Neck Bifurcation Intracranial Aneurysm

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

BRITEPath- Phase 2

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer